Skip to main content
. 2021 Feb 16;21:95. doi: 10.1186/s12872-021-01904-y

Table 4.

Univariate and multivariable analysis of 2-year adverse events

Variable Univariate analysis Multivariate analysis
HR (95 % CI) P value HR (95 % CI) P value
Age 1.02 (1.00, 1.07) 0.296
Male gender 0.40 (0.13, 1.22) 0.105 0.49 (0.10, 2.31) 0.363
BMI 0.94 (0.81, 1.11) 0.479
Smoking 0.84 (0.23, 3.06) 0.792
Alcohol 2.82 (0.92, 8.61) 0.069 0.98 (0.23, 4.16) 0.980
Hypertension 1.60 (0.44, 5.81) 0.476
False lumen patency
 Patent false lumen Reference 1
 Partial thrombosis 0.67 (0.15, 3.10) 0.608 0.50 (0.07, 3.28) 0.466
 Complete thrombosis 3.43 (0.74, 15.89) 0.115 4.14 (0.51, 33.35) 0.182
Distance of LSCA ≤ 2 cm 1.02 (0.28, 3.71) 0.976
Maximum diameter of abdominal aorta (cm) 1.07 (0.97, 1.18) 0.159 1.09 (0.92, 1.29) 0.316
SBP on admission (mmHg) 1.00 (0.97, 1.03) 0.907
DBP on admission (mmHg) 0.91 (0.83, 0.96) 0.003 0.86 (0.78, 0.95) 0.003
Temperature preoperatively (℃) 0.64 (0.14, 2.85) 0.558
Creatinine preoperatively (µmol/l) 1.00 (0.98, 1.02) 0.741
Platelet count preoperatively (×109/l) 0.99 (0.99, 1.00) 0.107
Preoperative NLR per SD 1.58 (1.11, 2.26) 0.011 1.98 (1.14, 3.44) 0.015
Alpha-blockers 3.60 (0.47, 7.68) 0.219
Beta-blockers 0.95 (0.31, 2.91) 0.929
ARBs 1.06 (0.24, 4.79) 0.939
ACEIs 1.12 (0.23, 4.81) 0.939
CCBs 0.47 (0.16, 1.46) 0.193 0.78 (0.14, 4.40) 0.776
Statins 0.67 (0.21, 2.16) 0.497
Timing of procedure
 Acute (1–14 days) Reference
 Subacute (14–92 days) 1.16 (0.39, 3.46) 0.787
ASA classification
 I Reference Reference
 II 0.54 (0.17, 1.77) 0.309 0.51 (0.10, 2.73) 0.433
 III 2.96 (0.57, 15.36) 0.195 3.19 (0.22, 46.42) 0.395
Adjunctive stents 3.48 (1.07, 11.32) 0.038 0.79 (0.13, 4.79) 0.800

HR hazard ratio, CI confidence interval, BMI body mass index, LSCA left subclavian artery, NLR neutrophil-to-lymphocyte ratio, SBP systolic blood pressure, DBP diastolic blood pressure, ASA American Society of Anesthesiologists